Assetmark Inc. cut its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 82.9% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 24,489 shares of the company's stock after selling 119,055 shares during the period. Assetmark Inc.'s holdings in Option Care Health were worth $767,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA acquired a new stake in shares of Option Care Health during the 2nd quarter valued at about $68,003,000. Magnetar Financial LLC lifted its stake in Option Care Health by 124.8% in the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company's stock valued at $68,750,000 after acquiring an additional 1,377,929 shares during the last quarter. Duquesne Family Office LLC grew its position in Option Care Health by 172.8% in the second quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company's stock worth $51,849,000 after acquiring an additional 1,185,613 shares in the last quarter. Hood River Capital Management LLC increased its stake in shares of Option Care Health by 77.2% during the 2nd quarter. Hood River Capital Management LLC now owns 1,729,029 shares of the company's stock worth $47,894,000 after purchasing an additional 753,208 shares during the last quarter. Finally, Fort Washington Investment Advisors Inc. OH bought a new position in shares of Option Care Health during the 2nd quarter valued at $18,774,000. Institutional investors and hedge funds own 98.05% of the company's stock.
Option Care Health Stock Performance
NASDAQ:OPCH traded down $0.26 during mid-day trading on Friday, hitting $21.93. 1,974,267 shares of the company's stock traded hands, compared to its average volume of 1,525,719. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a 50 day moving average of $28.62 and a two-hundred day moving average of $29.38. The firm has a market capitalization of $3.73 billion, a price-to-earnings ratio of 18.43, a price-to-earnings-growth ratio of 2.30 and a beta of 1.32. Option Care Health, Inc. has a 12 month low of $21.64 and a 12 month high of $34.63.
Analyst Ratings Changes
OPCH has been the subject of a number of recent research reports. Barrington Research decreased their price objective on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a report on Thursday, October 31st. Bank of America cut Option Care Health from a "buy" rating to a "neutral" rating and reduced their price target for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. JMP Securities increased their price objective on Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a report on Monday, September 30th. Truist Financial reduced their target price on Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a report on Friday, November 1st. Finally, The Goldman Sachs Group cut Option Care Health from a "buy" rating to a "neutral" rating and decreased their target price for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $30.83.
Read Our Latest Stock Analysis on Option Care Health
Insider Activity at Option Care Health
In other news, CFO Michael H. Shapiro sold 23,217 shares of the company's stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares of the company's stock, valued at approximately $7,654,461.15. This represents a 8.58 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the sale, the director now owns 21,339 shares of the company's stock, valued at $663,429.51. This trade represents a 69.02 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.64% of the company's stock.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.